Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

iPS Cell Differentiation01:22

iPS Cell Differentiation

3.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.2K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

28.2K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.2K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

5.7K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.7K
Stem Cell Culture01:17

Stem Cell Culture

6.3K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
6.3K
Source And Potency Of Stem Cells01:27

Source And Potency Of Stem Cells

6.5K
Stem cells are undifferentiated cells with extensive self-renewal properties that help them maintain their population during the fetal and adult stages of life. They can specialize in all cell types of the human body. However, their differential potential may vary and can be classified into five types. Stem cells can be (1) Totipotent, (2) Pluripotent, (3) Multipotent, (4) Oligopotent, and (5) Unipotent. Each stem cell has a specific origin; the fertilized egg or zygote is a totipotent cell and...
6.5K
Embryonic Stem Cells00:58

Embryonic Stem Cells

33.1K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
33.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiovascular Organoids With Adjustable Endothelial Composition via SOX17-Engineered hPSCs.

Biotechnology and bioengineering·2026
Same author

Unconventional auricular reconstruction using controlled scaffold buckling and chondrogenic cocktail containing muscle-derived cells.

Bioactive materials·2026
Same author

Irbesartan ameliorates high‑glucose‑induced epithelial‑mesenchymal transition by downregulating the expression of NLRP3 in HK‑2 cells.

Molecular medicine reports·2026
Same author

Mitochondria-targeted photodynamic nanoparticles boost antitumor immunity by suppressing mitophagy in osteosarcoma.

Bioactive materials·2026
Same author

The impact of silence pedagogy on vulnerable students' engagement in physical education: a mini-review.

Frontiers in psychology·2026
Same author

Super-Resolution Ultrasound for Microvascular-Based Differentiation of Benign and Malignant Choroidal Tumors: A Preliminary Study.

Ultrasound in medicine & biology·2026
Same journal

Oversimplified immunology is holding biomaterials back.

Nature reviews bioengineering·2026
Same journal

Digital twins and digital models of the human circulatory system.

Nature reviews bioengineering·2026
Same journal

A framework of digital biomarkers for neurodegenerative diseases.

Nature reviews bioengineering·2026
Same journal

Transparency of medical artificial intelligence systems.

Nature reviews bioengineering·2026
Same journal

Mechanomedicine.

Nature reviews bioengineering·2026
Same journal

Motion artefact management for soft bioelectronics.

Nature reviews bioengineering·2026
See all related articles

Related Experiment Video

Updated: Mar 7, 2026

Directed Differentiation of Induced Pluripotent Stem Cells towards T Lymphocytes
12:47

Directed Differentiation of Induced Pluripotent Stem Cells towards T Lymphocytes

Published on: May 14, 2012

19.4K

A Pluripotent Road to Immunoengineering.

Yun Chang1,2, Qing Deng2,3, Xiaoping Bao1,2

  • 1Davidson School of Chemical Engineering, Purdue University, West Lafayette, IN, US.

Nature Reviews Bioengineering
|March 6, 2026
PubMed
Summary
This summary is machine-generated.

Chimeric antigen receptor T cell therapy shows promise for blood cancers but faces challenges. Human pluripotent stem cells offer a scalable, cost-effective alternative for adoptive immunotherapy.

More Related Videos

Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells
10:57

Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells

Published on: October 24, 2019

11.0K
A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants
10:44

A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants

Published on: August 9, 2019

7.7K

Related Experiment Videos

Last Updated: Mar 7, 2026

Directed Differentiation of Induced Pluripotent Stem Cells towards T Lymphocytes
12:47

Directed Differentiation of Induced Pluripotent Stem Cells towards T Lymphocytes

Published on: May 14, 2012

19.4K
Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells
10:57

Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells

Published on: October 24, 2019

11.0K
A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants
10:44

A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants

Published on: August 9, 2019

7.7K

Area of Science:

  • Immunotherapy
  • Hematologic Oncology
  • Stem Cell Biology

Background:

  • Adoptive immunotherapy, especially chimeric antigen receptor T cells (CAR-T), has revolutionized hematologic malignancy treatment.
  • Current CAR-T therapy faces limitations including patient-specific cell engineering, high costs, and significant time commitments.
  • These challenges restrict the widespread application of CAR-T therapy.

Purpose of the Study:

  • To explore human pluripotent stem cells (hPSCs) as a potential alternative for adoptive immunotherapy.
  • To address the limitations of patient-derived CAR-T cells by leveraging hPSCs.
  • To investigate the feasibility of an off-the-shelf, scalable, and cost-effective cell therapy solution.

Main Methods:

  • Utilizing human pluripotent stem cells as a source for cell engineering.
  • Developing methods for scalable production of therapeutic cells from hPSCs.
  • Evaluating the potential for generating 'off-the-shelf' allogeneic cell products.

Main Results:

  • Human pluripotent stem cells present a viable alternative to autologous cell sources.
  • hPSC-derived therapies could overcome the variability associated with patient-derived cells.
  • This approach holds the potential for reduced manufacturing costs and increased scalability.

Conclusions:

  • Human pluripotent stem cells offer a promising platform for developing next-generation adoptive immunotherapies.
  • hPSC-based strategies can potentially democratize access to advanced cancer treatments.
  • This research paves the way for more accessible and affordable treatments for hematologic malignancies.